Search Results
You are looking at 1 - 6 of 6 items for
- Author: A. M. McNicol x
- Refine by access: All content x
Search for other papers by A. M. McNicol in
Google Scholar
PubMed
Search for other papers by M. A. G. Kubba in
Google Scholar
PubMed
Search for other papers by E. McTeague in
Google Scholar
PubMed
ABSTRACT
The immunohistochemically defined corticotroph population in the anterior pituitary gland of the adult male Sprague–Dawley rat has been quantified at 2 and 6 weeks after bilateral adrenalectomy using the stereological measurement, volume density (Vv). An approximately twofold increase in corticotroph Vv was demonstrated at 2 weeks in adrenalectomized rats compared with that in sham-operated controls and this was maintained at 6 weeks. Daily i.p. injections of ovine corticotrophin-releasing factor (CRF-41) induced a significant dose-related increase in corticotroph Vv when administered at doses of 25 and 50 μg/kg body weight, but this was less than the increase following adrenalectomy.
Assessment of changes in mitotic activity of the total anterior lobe of adult Sprague–Dawley rats and of the corticotroph population was also made after daily i.p. injections of 50 μg CRF-41/kg for 2 and 7 days. There was no increase in overall mitotic index at either time. However, the numbers of mitotic corticotrophs were significantly increased in CRF-injected animals compared with those in saline-injected rats. These results indicate a role for CRF-41 in the regulation of corticotroph growth.
J. Endocr. (1988) 118, 237–241
Search for other papers by A. M. McNicol in
Google Scholar
PubMed
Search for other papers by I. D. Penman in
Google Scholar
PubMed
Search for other papers by A. E. Duffy in
Google Scholar
PubMed
ABSTRACT
Using a metaphase arrest technique, mitotic activity was quantified in the adrenal cortex over a 24-h period in 14-day-old male Sprague–Dawley rats before functional rhythmicity of the hypothalamic pituitary-adrenal (HPA) axis is established, and after its onset, in 6- to 7-week-old rats. At all times, proliferative activity was greater in the younger animals, as previously reported. A significant circadian rhythm was identified in both groups, but the timing of the peak differed, lying between 17.00 and 21.00 h at 14 days and 11.00 and 15.00 h at 6–7 weeks. These results raise the possibility that functional rhythmicity of the HPA axis may alter an inherent proliferative rhythm.
Journal of Endocrinology (1989) 120, 307–310
Search for other papers by A. G. Howatson in
Google Scholar
PubMed
Search for other papers by M. Farquharson in
Google Scholar
PubMed
Search for other papers by A. Meager in
Google Scholar
PubMed
Search for other papers by A. M. McNicol in
Google Scholar
PubMed
Search for other papers by A. K. Foulis in
Google Scholar
PubMed
ABSTRACT
The distribution of α-interferon in human placental tissue was investigated by immunocytochemical study of paraffin wax-embedded tissue sections using a sheep α-interferon antiserum. Fifty-eight placentas of gestational ages from 8 to 40 weeks were examined.
α-Interferon was present in the syncytiotrophoblast of the chorionic villi of all placentas and was also in macrophages in 28 cases. The appearances suggest production of interferon in human placental trophoblast and, in view of its diverse biological effects, support the concept of a role for α-interferon in the complex series of events required for successful gestation.
J. Endocr. (1988) 119, 531–534
Search for other papers by A. M. McNicol in
Google Scholar
PubMed
Search for other papers by J. E. Murray in
Google Scholar
PubMed
Search for other papers by W. McMeekin in
Google Scholar
PubMed
ABSTRACT
Proliferative activity was measured in rat anterior pituitary cells in short-term culture by calculating the labelling index (LI), based on the immunohistochemical detection of cells incorporating the thymidine analogue bromodeoxyuridine. Basal LI was reproducible in the test system. Arginine vasopressin (AVP) induced a dose-related increase in LI up to 20 ng/ml. Corticotrophin-releasing factor-41 (CRF-41) had no effect at doses up to 20 ng/ml. However, in the presence of 10 ng CRF-41/ml, AVP induced a greater increase in LI at lower doses than did AVP alone. Fibroblast growth factor also induced a significant increase in LI. In the system used, epidermal growth factor and insulin had no effect on proliferation.
Journal of Endocrinology (1990) 126, 255–259
Search for other papers by A. M. McNicol in
Google Scholar
PubMed
Search for other papers by H. Thomson in
Google Scholar
PubMed
Search for other papers by C. J. R. Stewart in
Google Scholar
PubMed
The distribution of specifically stained corticotrophic cells has been studied in the pituitary glands of 11 dogs with pituitary-dependent hyperadrenocorticism. The results suggest that the disease is not a single entity, and that some cases are caused by primary abnormality of the pituitary gland whereas others appear to be the result of dysfunction of the hypothalamus or central nervous system.
The patterns correspond closely to those demonstrated in the human pituitary gland in Cushing's disease, and confirm that the canine disease is a useful model for the study of the pathogenesis of the variants of the condition.
Search for other papers by H. N. COHEN in
Google Scholar
PubMed
Search for other papers by J. A. FYFFE in
Google Scholar
PubMed
Search for other papers by W. A. RATCLIFFE in
Google Scholar
PubMed
Search for other papers by A. M. McNICOL in
Google Scholar
PubMed
Search for other papers by H. McINTYRE in
Google Scholar
PubMed
Search for other papers by J. S. KENNEDY in
Google Scholar
PubMed
Search for other papers by J. A. THOMSON in
Google Scholar
PubMed
The effects on pituitary–thyroid function of the commonly prescribed anti-bacterial preparations co-trimoxazole and co-trifamole, and their component drugs, have been studied in the rat and compared to the changes caused by propylthiouracil.
Co-trimoxazole and co-trifamole, in doses 20-fold in excess of a pharmacological dose administered for 10 days, produced marked changes in hormone levels consistent with blocking of thyroidal activity. Significant increases in thyroid gland weight, with histological evidence of hyperplastic goitre formation, were also demonstrated. Propylthiouracil produced less marked changes of thyroid hormone levels but higher levels of thyroid-stimulating hormone. Pharmacological doses of co-trimoxazole and co-trifamole and sulphamoxole, the sulphonamide component of co-trifamole, caused significant changes in thyroid hormone levels consistent with anti-thyroidal activity. In contrast, there was no evidence that trimethoprim, which is common to both preparations, or sulphamethoxazole, the sulphonamide component of co-trimoxazole, had an anti-thyroidal action, indeed, serum thyroxine levels were significantly increased at pharmacological dosage. We have concluded that the new commonly prescribed combination preparations retain the goitrogenic properties of the earlier sulphonamides.
